Xanadu's stock was a textbook trap that has now sprung, falling about 60% premarket as insiders exit. An S-1 registered about 294M shares for resale by existing holders, which brings the company nothing and floods the float of a startup with $4.6M in annual revenue. A multi-billion-dollar valuation was unsustainable, and as a post-SPAC name its hype premium evaporated once lockups and conversions hit. Brilliant technology doesn't make a safe stock when insiders rush for the exits. x.com 

Quantum computing stocks such as IonQ, Rigetti, Quantum Computing Inc, Arqit, SEALSQ, BTQ and HQ could catch a bid around Quantinuum's IPO. Quantinuum is raising about $1.46 billion at a roughly $14 billion valuation, the first traditional IPO of a full-stack quantum company, anchored by long-only demand. Big IPOs reprice whole sectors as allocators who missed the deal seek liquid exposure, as with Cerebras and SpaceX. The driver is positioning, not fundamentals, so these are very risky trades. … Show more

D-Wave Quantum is hard to justify as a $7B company trading at 50x 2028 sales in a highly speculative industry, and its CFO is resigning. x.com 

China SXT Pharmaceuticals is a short-squeeze candidate: short interest exceeds 20%, institutional ownership exceeds 100%, no shares are left to borrow and the cost to borrow is over 500%. It has the same setup as other low-float, high-short-interest plays; after coiling all day, a pop on incoming volume is only a matter of time because shorts are trapped. x.com  x.com